Correction: Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non‑rapidly progressive Alzheimer’s disease (Alzheimer's Research & Therapy, (2023), 15, 1, (106), 10.1186/s13195-023-01249-y)

Abstract

Following publication of the original article [1], the authors identified an error in Fig. 2 (the color coding of APOE genotypes E2/2 and E3/4 is wrong). APOE2/E2 is displayed as most frequent genotype but in fact, it is the least frequent genotype. The correct figure is given below. (Figure presented.) ApoE Genotype distribution at baseline. ApoE Genotype distribution in diagnostic groups. ApoE, apolipoprotein E; AD, Alzheimer’s disease; rpAD, rapidly progressive Alzheimer’s disease The original article [1] has been corrected.